ORAMED LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ORAMED LTD..The latest application filed is for "methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof".

Company Profile

21.15.29

ORAMED LTD. - Jerusalem IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for treating diabetes Grant 11,395,848 - Kidron July 26, 2	2022-07-26
Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof App 20220000986 - KIDRON; Miriam ; et al.	2022-01-06
Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same App 20210369626 - HERSHKO; Avraham ; et al.	2021-12-02
Methods and Compositions for Oral Administration of Exenatide App 20210322305 - Kidron; Miriam	2021-10-21
Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof App 20210244806 - Kidron; Miriam ; et al.	2021-08-12
Methods and Compositions for Oral Administration of Proteins App 20210113663 - KIDRON; Miriam	2021-04-22
Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof Grant 10,967,051 - Kidron , et al. April 6, 2	2021-04-06
Methods and Compositions for Treating Diabetes App 20210077588 - Kidron; Miriam	2021-03-18
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same Grant 10,933,022 - Hershko , et al. March 2, 2	2021-03-02
Methods and compositions for oral administration of proteins Grant 10,881,714 - Kidron January 5, 2	2021-01-05
Methods and Compositions for Treating Diabetes App 20190374615 - Kidron; Miriam	2019-12-12
Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same App 20190321303 - Hershko; Avraham ; et al.	2019-10-24
Methods and Compositions for Rectal Administration of Exenatide App 20190314275 - Kidron; Miriam	2019-10-17
Methods and compositions for treating diabetes Grant 10,398,762 - Kidron Sep	2019-09-03
Methods and compositions for oral administration of exenatide Grant 10,350,162 - Kidron July 16, 2	2019-07-16
Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof App 20190209655 - Kidron; Miriam ; et al.	2019-07-11
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same Grant 10,342,764 - Hershko , et al. July 9, 2	2019-07-09
Methods and Compositions for Oral Administration of Proteins App 20180369339 - Kidron; Miriam	2018-12-27
Methods and compositions for oral administration of proteins Grant 10,058,593 - Kidron August 28, 2	2018-08-28
Methods And Compositions For Treating Nafld, Hepatic Steatosis, And Sequelae Thereof App 20150335715 - KIDRON; Miriam ; et al.	2015-11-26
Methods And Compositions For Treating Diabetes App 20150017238 - Kidron; Miriam	2015-01-15
Protease Inhibitor-containing Compositions, Compositions Comprising Same, And Methods For Producing And Using Same App 20140377344 - Hershko; Avraham	2014-12-25
Methods And Compositions For Oral Administration Of Exenatide App 20130195939 - Kidron; Miriam	2013-08-01
Methods And Compositions For Oral Administration Of Proteins App 20110142800 - Kidron; Miriam ; et al.	2011-06-16
Methods And Compositions For Oral Administration Of Exenatide App 20110046053 - Kidron; Miriam	2011-02-24
Methods And Compositions For Oral Administration Of Proteins App 20110014247 - Kidron; Miriam	2011-01-20

Company Registrations

NCAGE Code	3852A	ORAMED LTD
CAGE Code	3852A	ORAMED LTD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.